Jones Financial Companies
DARE icon

Jones Financial Companies’s Dare Bioscience DARE Stock Holding History

Jones Financial Companies’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$828 Buy
+396
New +$885 ﹤0.01% 4645

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jones Financial Companies's DARE Position: Q2 2026 in Review

Jones Financial Companies opened a new position in Dare Bioscience (DARE) in Q2 2026: 396 shares worth $828. The stake represents ﹤0.01% of the portfolio and ranks #4645 among its holdings.

27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • Jones Financial Companies held 396 shares of Dare Bioscience worth $828 as of Q2 2026.
  • Dare Bioscience was a new Jones Financial Companies position in Q2 2026.
  • Dare Bioscience made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4645 holding.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.